D I Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.80 M
- Company Age 38 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.80 M
- Revenue Growth %
- Profit Growth -29.33%
- Ebitda -31.01%
- Net Worth -2.87%
- Total Assets -6.17%
About D I Laboratories
D I Laboratories Ltd (DILL) is a Public Limited Indian Non-Government Company incorporated in India on 31 July 1986 and has a history of 38 years and six months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.80 M.
The company has closed loans amounting to ₹2.80 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sandip Ghosh, Biman Saha, and Swarup Chakraborty serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239WB1986PLC041034
- Company No.
041034
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
31 Jul 1986
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at D I Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandip Ghosh  | Director | 10-Feb-1988 | Current |
| Biman Saha | Director | 25-Nov-2002 | Current |
| Swarup Chakraborty | Director | 25-Nov-2022 | Current |
Financial Performance of D I Laboratories.
D I Laboratories Ltd, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 29.33% decrease in profit. The company's net worth dipped by a decrease of 2.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of D I Laboratories?
In 2019, D I Laboratories had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kontest Chemicals LtdBiman Saha and Swarup Chakraborty are mutual person
Development Consultants Private LimitedSandip Ghosh is a mutual person
_PRIVATE_LIMITED.webp)
Dcg Data-Core Systems (India) Private LimitedSwarup Chakraborty is a mutual person
Bengal Dcl Housing Development Company LimitedSwarup Chakraborty is a mutual person
Scientech International Pvt. Ltd.Sandip Ghosh is a mutual person
- Economic And Entrepreneurship Development Foundation
Sandip Ghosh is a mutual person
Charges (Loans)
₹0
₹2.80 M
Charges Breakdown by Lending Institutions
- Uco Bank : 0.28 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Dec 1987 | Uco Bank | ₹2.80 M | Satisfied |
How Many Employees Work at D I Laboratories?
D I Laboratories has a workforce of 28 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of D I Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D I Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
